Isoray Announces Fourth Quarter and Full-Year Fiscal 2019 Financial Results

Stock Information for Isoray. (DE)

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Isoray. (DE)

Isoray and University of Cincinnati Physicians Company Sign Research Agreement to Study Treatment of Head and Neck Cancers
Second Ten Year Data Report Demonstrates Efficacy of Isoray's Cesium-131 Internal Radiation Therapy in the Treatment of Prostate Cancer
Isoray Announces Record Third Quarter Fiscal 2020 Financial Results
Centers for Medicare and Medicaid Services Approves Isoray's Application for Billing Codes for the Intraoperative Use of Cesium-131
Isoray To Announce Third Quarter Fiscal 2020 Financial Results on May 12, 2020
Isoray Announces Second Quarter Fiscal 2020 Financial Results
Isoray Collaborates with MIM Software to Deliver an Advanced Treatment Solution for Recurrent Head and Neck Cancers
Isoray To Announce Second Quarter Fiscal 2020 Financial Results on February 11, 2020

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.